Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib

NCT01217034 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

228

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Unresectable Hepatocellular Carcinoma
Carcinoma, Hepatocellular
Liver Neoplasm

Interventions

DRUG: TACE with sorafenib
PROCEDURE: TACE alone

Sponsor

Kindai University